Pregnancy in hyperprolactinemic women

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 3, 2002, Pages 265-267

  Mallamann, Elaine S ^a   Nácul, Andréa ^a   Spritzer, Poli Mara ^a  

^a Department of Physiology ^*  (Brazil)

Author keywords

Dopamine agonist; Hyperprolactinemia; Pituitary adenome; Pregnancy

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEADACHE; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; VERTIGO;

ADULT; FEMALE; HUMANS; HYPERPROLACTINEMIA; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 0036204606     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.810314.x     Document Type: Article

References (7)

1. Women with prolactinoma - Effect of pregnancy and lactation on serum prolactin and on tumor growth
2. Medical treatment of prolactinomas
3. Macroprolactinomas with suprasellar extension: Effect of bromocriptine withdrawal during one or more pregnancies
4. Experience relating to pregnancy, lactation, and the after-weaning condition of hyperprolactinemic patients treated with bromocriptine
5. Diagnosis and treatment of prolactinomas
6. Pituitary diseases in pregnancy
7. The maternal adenohypophysis